CINECA IRIS Institutional Research Information System

CRUCITTA, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.315
AS - Asia 2.411
EU - Europa 2.065
SA - Sud America 391
AF - Africa 192
OC - Oceania 16
Totale 9.390
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.185
IT - Italia 922
SG - Singapore 878
CN - Cina 594
BR - Brasile 323
HK - Hong Kong 316
SE - Svezia 235
VN - Vietnam 216
DE - Germania 176
GB - Regno Unito 155
FR - Francia 120
BG - Bulgaria 94
CI - Costa d'Avorio 92
AT - Austria 73
JP - Giappone 68
CA - Canada 67
IN - India 67
FI - Finlandia 64
NL - Olanda 53
RU - Federazione Russa 46
PL - Polonia 43
KR - Corea 40
TR - Turchia 38
BD - Bangladesh 30
SN - Senegal 29
MX - Messico 25
AR - Argentina 22
ID - Indonesia 20
NG - Nigeria 20
ES - Italia 19
IQ - Iraq 18
UZ - Uzbekistan 16
ZA - Sudafrica 16
SA - Arabia Saudita 14
MA - Marocco 13
AU - Australia 11
PH - Filippine 11
EC - Ecuador 10
CH - Svizzera 9
LT - Lituania 9
PK - Pakistan 9
UA - Ucraina 9
IL - Israele 8
VE - Venezuela 8
JO - Giordania 7
MY - Malesia 7
TW - Taiwan 7
UY - Uruguay 7
CR - Costa Rica 6
CZ - Repubblica Ceca 6
KE - Kenya 6
KZ - Kazakistan 6
PA - Panama 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BE - Belgio 5
DO - Repubblica Dominicana 5
JM - Giamaica 5
NP - Nepal 5
PT - Portogallo 5
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
LB - Libano 4
NZ - Nuova Zelanda 4
PY - Paraguay 4
RO - Romania 4
SV - El Salvador 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
GT - Guatemala 3
IR - Iran 3
LK - Sri Lanka 3
TN - Tunisia 3
AM - Armenia 2
BH - Bahrain 2
BM - Bermuda 2
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
LV - Lettonia 2
NO - Norvegia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IE - Irlanda 1
KG - Kirghizistan 1
LY - Libia 1
ML - Mali 1
Totale 9.383
Salva come PNG Salva come JPEG
Città #
Ashburn 540
Singapore 448
Dallas 401
Santa Clara 321
Hong Kong 310
San Jose 306
Fairfield 262
Chandler 211
Woodbridge 164
Houston 163
Shanghai 152
Seattle 141
New York 120
Pisa 118
Boardman 114
Los Angeles 108
Florence 105
Wilmington 96
London 95
Sofia 94
Abidjan 92
Beijing 87
Cambridge 84
Milan 75
Vienna 67
Ho Chi Minh City 66
Tokyo 63
Frankfurt am Main 60
Serra 59
Munich 56
Princeton 56
Ann Arbor 55
Hefei 51
Lauterbourg 51
Lawrence 48
Hanoi 44
Rome 43
Turin 41
Council Bluffs 38
Medford 38
Seoul 35
Warsaw 35
Dakar 29
Istanbul 29
São Paulo 28
Turku 28
Redondo Beach 27
Buffalo 26
Ottawa 26
San Diego 21
Cascina 20
Helsinki 20
Lagos 20
Ogden 19
Dong Ket 16
Montreal 15
Nuremberg 15
Dearborn 14
Fuzhou 14
Tashkent 14
Brooklyn 13
Chicago 13
Denver 13
Livorno 13
Venice 13
Bremen 12
Mumbai 12
Paris 12
Rio de Janeiro 12
Toronto 12
Washington 12
Brasília 11
Chiesina Uzzanese 11
Des Moines 11
San Francisco 11
Boulder 10
Chennai 10
Genoa 10
Lucca 10
Marseille 10
Naples 10
Orem 10
Phoenix 10
Quanzhou 10
Columbus 9
Da Nang 9
Düsseldorf 9
Guangzhou 9
Lappeenranta 9
Mexico City 9
Nanjing 9
Redwood City 9
Stockholm 9
Atlanta 8
Belo Horizonte 8
Jakarta 8
Johannesburg 8
San Giuliano Terme 8
Amsterdam 7
Changsha 7
Totale 6.300
Salva come PNG Salva come JPEG
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 323
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer 217
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 202
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 201
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 199
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 193
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer 192
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 189
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 188
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 186
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 183
Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC 180
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 178
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 178
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report 174
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats 171
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide 169
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients 168
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 167
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 167
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 165
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 161
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 159
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 156
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 154
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 153
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 153
Circulating biomarkers of response to immunotherapy in cancer treatment 151
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 151
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 147
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 145
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 145
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer 143
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival 142
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide 137
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA 133
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA 130
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 129
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients 128
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 127
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 127
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 125
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 122
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 122
ErbB in NSCLC as a molecular target: Current evidences and future directions 122
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 120
β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation 118
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours 116
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 116
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone 115
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics 114
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer 112
Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview 109
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 108
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies 107
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation 106
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs 105
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma 105
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy 102
Insights from Multigene Panel Sequencing and Comparative Analysis of Metaplastic Carcinoma of the Breast 102
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 102
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients 102
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 93
Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low-grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis? 89
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies 83
Artificial intelligence-based pharmacological approach in non-small cell lung cancer in the precision medicine era 30
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients 29
HIF1A, ADRB3, and VEGFA gene expression in human cord blood across gestation: insights toward a pharmacological artificial placenta 24
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer 24
null 15
AAV-Mediated Base Editing for Correction of RSPH4A Mutations in Primary Ciliary Dyskinesia: A Proof-of-Concept Study 12
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 3
Totale 9.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022523 7 8 6 4 98 98 46 21 33 30 34 138
2022/20231.061 106 136 89 51 92 107 24 75 259 13 99 10
2023/2024809 53 66 123 43 67 147 43 28 20 46 84 89
2024/20252.418 74 72 39 126 254 280 170 144 244 284 284 447
2025/20263.279 273 404 338 390 354 195 483 175 190 292 123 62
Totale 9.613